IMMUNOLIFE, a Phase 2 randomized exploratory study, will evaluate the potential of MaaT033 in combination with Cemiplimab versus Best Investigator Choice (i.e.: second line) in enhancing disease ...

Extremophile molds are invading art museums and devouring their collections. Stigma and climate change have fueled their ...

AI is reshaping brand strategy. As agentic AI scales content marketing, brands must build entertainment fields, creating loyalty and gravity beyond transactions.

Adding elraglusib to chemotherapy significantly increases overall survival in patients with previously untreated metastatic PDAC.

Last summer I polled the great art houses of Europe with a seemingly straightforward question: Had they had any recent experiences with mold in their collections? Mold is a perennial scourge in ...

Background Although 90% of youth live in low- and middle-income countries, only 10% of child mental health research is ...

Background Anxiety disorders are persistent, functionally impairing conditions with high societal burden. In contrast, ...

Customer deposits grew at a healthy pace, up 9% annualized. Credit quality was strong with net charge-offs just five basis ...

S&P Global said in a recent analysis that copper supply would fall short of demand for the next 15 years, barring significant increases in production.

As mentioned before, Denison Mines has approximately $368.04 million worth of net non-uranium assets, along with $155.80 ...

MaaT Pharma (EURONEXT: MAAT ? the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for ...